88863-6
LaboratoryLung cancer antibody panel - Serum or Plasma by Immunoassay
Definition
This panel of terms was developed by, but not limited to, Oncimmune. Elevated levels of the autoantibodies in this panel against lung tumor proteins are present in 40% of lung cancer patients at the time the malignancy is diagnosed. This panel of six autoantibodies is used to assist in the early diagnosis of lung cancer in patients at high risk of developing it, either because of risk factors such as smoking or the presence of a nodule on a CT scan.[PMID: 21733826]
LOINC 6-Axis Classification
Component
Lung cancer antibody panel
Property
-
Time Aspect
Pt
System
Ser/Plas
Scale Type
-
Method Type
IA
Details
Class
PANEL.SERO
Order/Observation
Order
Short Name
Lung cancer antibody panel SerPl IA
Display Name
Lung cancer antibody panel IA
Related Names
Frequently Asked Questions
What is LOINC code 88863-6?
LOINC code 88863-6 identifies "Lung cancer antibody panel - Serum or Plasma by Immunoassay". This panel of terms was developed by, but not limited to, Oncimmune. Elevated levels of the autoantibodies in this panel against lung tumor proteins are present in 40% of lung cancer patients at the time the malignancy is diagnosed. This panel of six autoantibodies is used to assist in the early diagnosis of lung cancer in patients at high risk of developing it, either because of risk factors such as smoking or the presence of a nodule on a CT scan.[PMID: 21733826]
What does 88863-6 measure?
This code measures Lung cancer antibody panel in Ser/Plas. It belongs to the PANEL.SERO class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.